1. Home
  2. CTSO vs REFR Comparison

CTSO vs REFR Comparison

Compare CTSO & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.39

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

N/A

Current Price

$0.46

Market Cap

21.6M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
REFR
Founded
1997
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
21.6M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
CTSO
REFR
Price
$0.39
$0.46
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
58.7K
70.8K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
$1,488,642.00
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.35
$0.35
52 Week High
$1.19
$2.70

Technical Indicators

Market Signals
Indicator
CTSO
REFR
Relative Strength Index (RSI) 52.89 36.19
Support Level $0.36 $0.35
Resistance Level $0.40 $0.53
Average True Range (ATR) 0.03 0.05
MACD 0.00 0.01
Stochastic Oscillator 80.00 45.94

Price Performance

Historical Comparison
CTSO
REFR

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

Share on Social Networks: